Matthew Yates
About Matthew Yates
Matthew Yates is a Medical Scientist specializing in Cell Therapy at Kite Pharma, where he has worked since 2020. He holds a Ph.D. in Cell/Cellular and Molecular Biology from the University of East Anglia and has extensive experience in the field, including roles at NHS Blood and Transplant and The Binding Site.
Current Role at Kite Pharma
Matthew Yates serves as a Medical Scientist specializing in Cell Therapy at Kite Pharma. He has held this position since 2020, contributing to the development and implementation of innovative cell therapy solutions. His role involves conducting research and collaborating with cross-functional teams to advance Kite Pharma's mission in the field of oncology.
Previous Experience in Healthcare
Prior to his current role, Matthew Yates worked at NHS Blood and Transplant as an STP in Haematology and Transfusion Science from 2014 to 2016. His experience in this position provided him with a strong foundation in blood and transplant services. He also served as a Field Medical Science Liaison at The Binding Site from 2016 to 2020, where he engaged with healthcare professionals to support product knowledge and clinical applications.
Education and Expertise
Matthew Yates earned his Doctor of Philosophy (Ph.D.) in Cell/Cellular and Molecular Biology from the University of East Anglia, where he studied from 2010 to 2014. He also holds a Bachelor’s Degree in Applied Biomedical Sciences from Keele University, completed from 2007 to 2010. His academic background equips him with extensive knowledge in cellular biology and biomedical sciences.
Academic Contributions
During his time at the University of East Anglia, Matthew Yates worked as a Laboratory Demonstrator from 2010 to 2014 in the School of Biological Sciences. In this role, he supported undergraduate students in their laboratory work, enhancing their understanding of biological sciences through practical experience.